1. Home
  2. MURA vs WPRT Comparison

MURA vs WPRT Comparison

Compare MURA & WPRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MURA
  • WPRT
  • Stock Information
  • Founded
  • MURA 2013
  • WPRT 1995
  • Country
  • MURA Ireland
  • WPRT Canada
  • Employees
  • MURA N/A
  • WPRT N/A
  • Industry
  • MURA
  • WPRT Industrial Machinery/Components
  • Sector
  • MURA
  • WPRT Industrials
  • Exchange
  • MURA Nasdaq
  • WPRT Nasdaq
  • Market Cap
  • MURA 45.8M
  • WPRT 49.9M
  • IPO Year
  • MURA N/A
  • WPRT 1995
  • Fundamental
  • Price
  • MURA $2.46
  • WPRT $2.93
  • Analyst Decision
  • MURA Strong Buy
  • WPRT Buy
  • Analyst Count
  • MURA 4
  • WPRT 3
  • Target Price
  • MURA $13.00
  • WPRT $6.33
  • AVG Volume (30 Days)
  • MURA 106.6K
  • WPRT 12.8K
  • Earning Date
  • MURA 08-12-2025
  • WPRT 08-12-2025
  • Dividend Yield
  • MURA N/A
  • WPRT N/A
  • EPS Growth
  • MURA N/A
  • WPRT N/A
  • EPS
  • MURA N/A
  • WPRT N/A
  • Revenue
  • MURA N/A
  • WPRT $295,680,000.00
  • Revenue This Year
  • MURA N/A
  • WPRT N/A
  • Revenue Next Year
  • MURA N/A
  • WPRT N/A
  • P/E Ratio
  • MURA N/A
  • WPRT N/A
  • Revenue Growth
  • MURA N/A
  • WPRT N/A
  • 52 Week Low
  • MURA $0.95
  • WPRT $2.50
  • 52 Week High
  • MURA $4.74
  • WPRT $6.50
  • Technical
  • Relative Strength Index (RSI)
  • MURA 44.84
  • WPRT 51.55
  • Support Level
  • MURA $2.51
  • WPRT $2.76
  • Resistance Level
  • MURA $2.66
  • WPRT $2.95
  • Average True Range (ATR)
  • MURA 0.09
  • WPRT 0.12
  • MACD
  • MURA -0.02
  • WPRT 0.01
  • Stochastic Oscillator
  • MURA 20.08
  • WPRT 56.59

About MURA Mural Oncology plc

Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.

About WPRT Westport Fuel Systems Inc

Westport Fuel Systems Inc is an organization engaged in the engineering, manufacturing, and supply of alternative fuel systems and components for transportation applications. It has three operating segments; the Original Equipment Manufacturers segment-design, manufacture, and sell alternative fuel systems, components and electronics, and related engineering services, to OEMs that serve light-duty, medium-duty, and heavy-duty customers, the Independent Aftermarket segment includes IAM products, conversion kits, and components allow for the conversion of vehicles after being sold to the end-user through a network of dealers and installers, and Corporate includes public company activities, corporate oversight, financing and capital allocation.

Share on Social Networks: